The Drug Science Podcast

Tune in to the latest episode of the drug science podcast where David Nutt meets with Tim Kerr, a doctoral research student in Psychiatry at King’s College London. Tim discusses his journey from slowly falling into drug addiction and dealing whilst studying for his medical degree eventually leading to arrest and imprisonment. Tim shares how he used this time in an open prison to apply for and study a Neuroscience masters with Kings College London with the support of the Longford trust, a charity that supports people with lived experience of prison to access higher education.  The Longford TrustHoward League for Penal ReformNHS Practitioner HealthAlcoholic liver diseaseJaundiceEcstasyKetamineCocaineFreud and cocaineNitrous oxideGHB SpiceWeedVenlafaxineModafinil Open and closed PrisonAlcoholics Anonymous ★ Support this podcast ★

Join us in the latest episode of the Drug Science Podcast where David Nutt meets with Psychedelic psychotherapy experts Laurie Higbed and Owain Winfield to dive into how to use psychedelics in psychotherapy. In this episode, they discuss the different techniques used with different psychedelics for different conditions to optimise this type of therapy and why these differences are necessary. They discuss MDMA, Ketamine and Psilocybin in a range of applications including trauma and addictions.MDMAKetaminePsilocybinSubstance MisusePTSDMAPSMDMA study into Substance Use DisorderCompass PathwaysCompass Pathways Psilocybin for Treatment Resistant DepressionAwakn life sciencesAmygdalaLink in show notes ★ Support this podcast ★

In this discussion, trauma-based psychiatrist Bessel van der Kolk shares insights from his groundbreaking work on trauma's effects on the body and mind. He delves into innovative treatments like EMDR and the potential of psychedelics, particularly MDMA, in healing trauma. Bessel discusses the historical challenges in trauma research and critiques traditional psychiatric assessments, advocating for a more compassionate approach. With a focus on neuroplasticity and the impact of childhood experiences, he presents a transformative perspective on mental health treatment.

In this episode of the Drug Science Podcast, David Nutt meets with psychopharmacologist Phil Cowen and Psychiatrist Sameer Jauhar  to discuss the neuroscience behind and treatments for depression. Within the episode they touch on various neurotransmitters involved in depression as well as research studies into each of their impact, stigma around antidepressants and the role of psychedelics in treatment.  DepressionSerotoninTryptophanHamilton depression scaleAntidepressantsGeddes paper on preventing relapseSupport the Podcast ★ Support this podcast ★

In this episode of the Drug Science podcast, we speak with Josh Dugdale of the Wasing Estate, described as a "mindful aristocrat." He shares his experiences with Ayahuasca in the Amazon and how they influenced his journey upon returning to the UK. Josh discusses the creation of a mindful and spiritual festival during the pandemic, its evolution over time, and its wider impact. He also explores the challenges surrounding psilocybin access rights, the changes needed in this area, and what the future of psychedelic reform might look like.Medicine Festival Psilocybin Access RightsAyahuascaPsilocybinMDMADrug Science Reschedule PsilocybinMedical CannabisPTSD Veterans PTSDIndustrial Hemp LicensingDEFRASubscribe to podcast  ★ Support this podcast ★

Prof. Ravi Das, a psychopharmacology expert at UCL, dives into innovative treatments for addiction and anxiety. He discusses the groundbreaking largest DMT study and its implications for memory reconsolidation. The conversation highlights the ethical landscape of psychedelic research and the potential effectiveness of DMT compared to traditional therapies. Taking a closer look at memory reconsolidation, he explains how targeting unstable memories could disrupt cravings and anxiety conditions, paving the way for future mental health treatments.

Tune in to the latest episode of the drug science podcast where we meet with Dr James Morgan, Prof Chris Chandler and Prof Jo Neill, the founders of Street Drugs Discussions (SDD). They discuss the process which led to them founding SDD, a series of webinars featuring experts on drug policy and drugs featuring topics surrounding overdose prevention centres, trafficking, specific substances and more. They reflect on the journey which got them to their current position as well as future hopes for SDD. Further, in this episode, the speakers discuss specific research conducted into long term heroin use and learning theory of addiction.   Street Drugs DiscussionsBuvidal WedinosBarodpsycareDiamorphine assisted treatmentLeapNeil Woods EpisodeNeedle exchangeTrainspottingHeroinCrack cocaineNicotineAlcohol MDMAmorphineDrug Science Community Member ★ Support this podcast ★

A conversation between Prof David Nutt and research scientist Dr Matthew X. Lowe.Dr Matthew X. Lowe PhD is Director of Research for Realm of Caring and Executive Director for Unlimited Sciences, a not-for-profit, observational research organisation with a focus on cannabis and psychedelic use by underrepresented population groups and a toll-free info line providing evidence-based support for anyone using psychedelics.In this episode, they discuss the vital role of observational and longitudinal research when it comes to the medicalisation of cannabis and psychedelics — and the importance for safetyof bringing real-world data into our collective knowledge base.They start with the genesis of Realm of Caring and Unlimited Sciences. Both organisations were conceived following first-hand experience of the banned compounds they research being profoundly medically transformative — inspiring co-founder Heather Jackson to grow related research and make it freely available to all who stand to benefit from such education. The origin stories of the organisations are followed by Dr Lowe’s personal route to his current research role and the roots of his passion for pursuing psychedelic research questions.Their focus then shifts to the present day with a comparison of roadblocks and red tape around researching cannabis and psychedelics in the UK and the US, noting the pioneering role that parents so often play in advocating for research into medicinal cannabis. Next comes a deeper exploration of specific properties of psychedelics that relate to their potential therapeutic applications, including their anti-addictive nature and positive habit-forming potential resulting from the neuroplastic window they potentiate — Unlimited Sciences has conducted the world’s largest naturalistic study on psilocybin use with further papers coming out on these implications.For the remainder of the episode, Prof David Nutt and Dr Matthew Lowe go into specifics on several key projects from Realm of Caring and Unlimited Sciences, including:-       The Realm of Caring Observational Research Registry, being done in collaboration with Johns Hopkins Cannabis Science Laboratory. This ongoing research is an IRB-approved online survey study looking at the effects on a variety of health conditions, in people who do and do not use cannabis. It is open to everyone in the world with internet access.  -       The Cannabis and Health Research Initiative (CHRI), another collaboration between Johns Hopkins and Realm of Caring, examining the patient-level impact of therapeutic cannabis use, through data collection and dissemination — aiming to aid clinical decision making and policymaking. And finally, two ceremonial research projects looking at ayahuasca, foregrounding the role of community and context in ceremonial psychedelic experiences — both exemplifying Unlimited Sciences’ diversification of the evidence base on psychedelics by collecting real world data on underrepresented population groups: -       With subjects who were Arabic-speaking women, a study exploring the psychological benefits of ayahuasca for refugees — with DrugScience collaborator Dr Robin Carhart-Harris.  -       And, currently in data analysis, with first results set to release in 2025, an IRB-approved study about ayahuasca use in the LGBTQIA+ community in collaboration with Costa Rica plant medicine retreat Jungle Gayborhood, with an emphasis on the importance of set and setting being truly safe spaces in the sense of meeting the specific needs of participants involved. Find out more about Dr Matthew X. Lowe and Unlimited Sciences below! Dr Matthew X. Lowe Realm of CaringUnlimited Sciences The Psychedelic Info LineCharlotte’s Web, Charlotte Figi and Realm of CaringRealm of Caring’s research libraryLong-term CBD study (Realm of Caring)Observational Research Registry (Realm of Caring)World’s largest naturalistic study on psilocybin use (Unlimited Sciences)Psychological benefits of ayahuasca for refugees (Unlimited Sciences)Jungle GayborhoodThe LGBTQIA+ study  ★ Support this podcast ★

Tune in to the latest episode of the drug science podcast where Prof Nutt meets with several Drug Science Community members for a session of “Ask David Anything”. Together, they explore questions such as the use of cannabis as a psychoactive substance in psychedelic therapy and the latest developments in regulatory decisions on psychedelic-assisted psychotherapy.   CannabisTHCCBDMDMAPsilocybinKetamineOxford Ketamine ClinicMike Jay Psychonaughts bookBreathworkPsychedelic Cannabis book Daniel McqueenTreatment resistant depressionPTSDMaps ★ Support this podcast ★

In the latest episode of the Drug Science Podcast, David Nutt sits down with Zoe Cormier, author of  ‘Sex, Drugs and Rock and Roll’. In this episode, Zoe draws upon her two great passions of music and science and how these lead to her interest around Drugs - she discusses the current landscape of drug policy, drawing upon similarities and differences between the UK, Canada, and the US. She shares insight on the political situation in the US, with reference to recent elections and the potential impact this may have on future drug policy.  Sex, Drugs and Rock and Roll BookCannabisLSDPsilocybinMDMADMTMDMA for PTSDMAPS CanadaMAPS IncidentSchizophreniaSkunkInuitsDonald TrumpJoe BidenMonty PythonRoald DahlManifest destinyGlastonbury festivalSmall Pharma FibromyalgiaBreaking ConventionSupport the podcast ★ Support this podcast ★